Clinical TrialsSearch results
Number of results: 1050
Completed
- A 52-week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL combined with insulin aspart, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin. (NN1535-4593:COMBINE 3)
- type 2 diabetes
- Miwa Hirotaka
- 2021-11-27
Completed
- A Bioequivalence Study of RTA 402 5 mg Tablets and 5 mg Capsules Under Fed Condition
- Diabetic kidney disease
- Mukai Kazuya
- 2023-07-01
Completed
- A clinical trial of China-made recombinant SARS-CoV-2 vaccine (Sf9 cells)
- Prevention of COVID-19
- Fujita Yasuyuki
- 2021-07-29
Completed
- A Double-Blind Study to Evaluate Efficacy and Safety of NPC-12G in Patients with Neurofibromatosis type 1
- Neurofibromatosis type 1
- Kaneda Mari
- 2019-04-22
Completed
- A non-interventional, single-arm, multicentre, prospective study investigating the glycaemic control and treatment pattern associated with the use of Xultophy (IDegLira) in a real-world adult population with type 2 diabetes mellitus in Japan.(NN9068-4743)
- Type 2 Diebetes Mellitus
- Sudoh Yuki
- 2021-04-21
Completed
- A phase 1 study of VLPCOV-01 in COVID-19 vaccinated healthy subjects
- Prevention of infectious disease caused by SARS-CoV-2
- Nobuaki Sato
- 2022-02-01
Completed
- A phase 2 study of VLPCOV-01 in COVID-19 vaccinated healthy subjects
- Prevention of infectious disease caused by SARS-CoV-2
- Sato Nobuaki
- 2022-09-12
Completed
- A phase II study of preoperative DOS for cStage III gastric cancer
- Gastric cancer
- Kurokawa Yukinori
- 2019-03-04
Completed
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Three-way Crossover Trial to Evaluate the Efficacy and Safety of Two Dose Levels of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II
- Hereditary Angioedema
- Smith Michael
- 2023-02-28